LUTATHERA® (lutetium Lu 177 dotatate)

Your guide to gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and treatment with LUTATHERA® (lutetium Lu 177 dotatate)

What is LUTATHERA?

LUTATHERA is a prescription medicine used to treat adults with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut.

IMPORTANT SAFETY INFORMATION1:

LUTATHERA can cause serious side effects and if you experience these side effects, your healthcare provider may need to adjust or stop your treatment. You should always follow your healthcare provider’s instructions. Serious side effects may include:

  • Radiation Exposure: Treatment with LUTATHERA will expose you to radiation which can contribute to your long-term radiation exposure. Overall radiation exposure is associated with an increased risk for cancer. The radiation will be detectable in your urine for up to 30 days following…See More

Your guide to GEP-NETs and treatment with LUTATHERA®

Learning that you have a somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NET) and receiving LUTATHERA—peptide receptor radionuclide therapy (PRRT)—can be difficult for you and those around you to understand and process.

What’s more, because GEP-NETs are a rare disease, some patients may find it difficult to find the kind of information and support they need.
This website has been developed to help you learn more about GEP-NETs and treatment with LUTATHERA.

Check back often, as the information in this website will be updated as it becomes available. As always, if you have specific questions about GEP-NETs, treatment with LUTATHERA, or are experiencing side effects, talk with your healthcare team. They are there to support you throughout your journey.

LEARN MORE ABOUT

GEP-NETs

Learn more about GEP-NETs and their signs and symptoms

LEARN MORE ABOUT

Find a Treatment Site

Find a LUTATHERA treatment site in the United States

What is LUTATHERA?

LUTATHERA® (lutetium Lu 177 dotatate) is a prescription medicine used to treat adults with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut.





What is LUTATHERA?

LUTATHERA® (lutetium Lu 177 dotatate) is a prescription medicine used to treat adults with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut.

home_logo
Patient Discussion Guide
You are now leaving the LUTATHERA.com website. Advanced Accelerator Applications USA, Inc. is not responsible for the content on external websites.